Phase-I randomized trial of doxorubicin hydrochloride liposome injection versus Caelyx® in multiple myeloma-Reference-Cited by-同舟云学术

Phase-I randomized trial of doxorubicin hydrochloride liposome injection versus Caelyx® in multiple myeloma

Published:2017-10-10 Issue:6 Volume:59 Page:1478-1481
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Bhowmik Shravanti¹,Bhowmick Subhas²,Maiti Kuntal¹,Chakra Amaresh²,Shahi Pradeep²,Rajamannar Thennati²

Affiliation:

1. Sun Pharma Advanced Research Company Ltd, Mumbai, Maharashtra, India;

2. Sun Pharma Advanced Research Centre, Sun Pharmaceutical Industries Ltd, Tandalja, Vadodara, India

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1382692

Reference8 articles.

1. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. National Comprehensive Cancer Network (NCCN). Guidelines for patients: multiple myeloma. Version 1. 2016. Available at: https://www.nccn.org/patients/guidelines/myeloma/files/assets/common/downloads/files/myeloma.pdf [cited 2017 Apr 24].

3. Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II study

4. An open-label phase I/II study of cyclophosphamide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed myeloma

5. Mature results of MM-011: A phase I/II trial of liposomal doxorubicin, vincristine, dexamethasone, and lenalidomide combination therapy followed by lenalidomide maintenance for relapsed/refractory multiple myeloma

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the In Vitro-In Vivo Nexus: Advanced correlation models predict clinical performance of liposomal doxorubicin;International Journal of Pharmaceutics;2024-04

2. Rescue of p53 functions by in vitro‐transcribed mRNA impedes the growth of high‐grade serous ovarian cancer;Cancer Communications;2023-12-22

3. Effect of Paclitaxel Combined with Doxorubicin Hydrochloride Liposome Injection in the Treatment of Osteosarcoma and MRI Changes before and after Treatment;Evidence-Based Complementary and Alternative Medicine;2022-07-30

4. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway;Journal of Cellular Biochemistry;2018-12-23

5. Two multicenter Phase I randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Doxil® or Caelyx® in advanced ovarian cancer;Cancer Chemotherapy and Pharmacology;2018-07-11